Antibiotic use in patients with a history of antibiotic allergy, including anaphylaxis

Overview

Prescribing antibiotics in a patient with a reported history of anaphylaxis to a specific antibiotic class (most often penicillin) requires distinguishing a genuine IgE-mediated allergy from a mislabelled reaction (intolerance, viral rash, non-immune adverse effect) - since an inaccurate label unnecessarily restricts access to first-line, often more effective and narrower-spectrum agents
Reported penicillin allergy is common (affecting a substantial minority of patients), but the large majority of these labels do not reflect a genuine, current IgE-mediated allergy when formally assessed

A confirmed IgE-mediated reaction reflects mast cell degranulation via specific drug-protein hapten complexes; cross-reactivity between beta-lactam classes is lower than traditionally taught - the historically quoted high cephalosporin cross-reactivity rate with penicillin allergy substantially overestimated true risk, largely reflecting early-generation cephalosporin manufacturing contamination rather than genuine shared antigenicity

A detailed history (reaction type, timing, and severity) distinguishes low-risk (non-specific rash, GI upset, remote/unclear history) from high-risk (anaphylaxis, angioedema, respiratory compromise) presentations
Formal allergy testing (skin testing, and in appropriate low-risk patients, direct oral challenge) can confirm or exclude true allergy and is increasingly used proactively ("penicillin allergy delabelling") given the clinical and antimicrobial stewardship benefits of an accurate label

Confirmed/high-risk true anaphylaxis history: avoid the culprit class and closely related cross-reactive agents; select an alternative antibiotic class matched to the indication, accepting a broader-spectrum or less optimal option where necessary
Low-risk/unclear history: refer for allergy testing/delabelling where feasible, given the stewardship and clinical benefit of restoring access to first-line beta-lactam therapy

Penicillin allergy delabelling (a growing antimicrobial stewardship priority), cephalosporin cross-reactivity (lower than historically taught), anaphylaxis vs non-allergic adverse effect distinction, alternative agent selection when true allergy confirmed
Most reported penicillin allergy labels do not reflect a genuine current allergy - given the stewardship cost of unnecessarily avoiding first-line beta-lactams (broader-spectrum, often less effective alternative agents, higher resistance selection pressure), a detailed allergy history and, where appropriate, formal testing/delabelling should be actively pursued rather than automatically avoiding the whole drug class

4 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.